Lysophospholipid Mediators in Health and Disease
November 2021
in “
Annual review of pathology
”
Studysummary This review discusses the regulatory roles of lysophospholipids like LPA and S1P in diseases such as fibrosis, neuropathic pain, and cancer, but reports no new clinical results.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The review article "Lysophospholipid Mediators in Health and Disease" discusses the roles of lysophospholipids, particularly lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P), in various physiological and pathological processes. Key findings include the involvement of LPA in hair growth, with genetic defects in the LIPH gene linked to hair growth deficiencies and the role of LPA and its receptor P2Y5 in maintaining human hair growth. Additionally, LPA signaling is implicated in lymphocyte migration and immune responses, while S1P signaling is crucial for vascular development and immune cell positioning. The review highlights the therapeutic potential of targeting these pathways in diseases such as cancer, fibrosis, and immune disorders.